[Skip to Content]
[Skip to Content Landing]
Article
December 1939

TREATMENT OF FUNGOUS INFECTIONS WITH ETHYL IODIDE INHALATIONSA REVIEW

Author Affiliations

BOSTON

From the Departments of Dermatology, Beth Israel Hospital and Massachusetts General Hospital.

Arch Derm Syphilol. 1939;40(6):962-973. doi:10.1001/archderm.1939.01490060100009
Abstract

The purpose of this paper is to bring up to date the subject of quantitative inhalation therapy in general, and ethyl iodide inhalation in particular. This paper contains data previously reported plus additional information gathered since the publication of the last paper on this subject. It deals with the following topics:

  • General considerations

  • Chemistry of ethyl iodide

  • Fate of ethyl iodide in the body

    1. Amount of ethyl iodide retained in the body at the end of the inhalation period.

    2. Amount of ethyl iodide exhaled after the end of the inhalation period.

    3. Excretion of iodide in the urine.

  • Clinical considerations

GENERAL CONSIDERATIONS  Iodide therapy has been used for years in cutaneous and systemic fungous infections. The usual methods of administration have been, first, oral and, later, intravenous. Quantitative inhalation therapy had not been reported previous to the publication by my associates and me of

First Page Preview View Large
First page PDF preview
First page PDF preview
×